Fri, 2 October, 9:00-10:00
Chairs:
- Serum lipidomics reveals altered fatty acid partitioning and membrane lipid remodeling in Spinal and Bulbar Muscular Atrophy, SBMA (A. Rosenbohm, Ulm)
- Temporal multi-omics profiling reveals progressive adipose-lipid-metabolite network rewiring in ALS (S. Krishnamurthy, Ulm)
- Where Are We with the premodiALS Study, and What Is Planned Next? (L. Tzeplaeff, TUM München)
- LIPCAL-ALS II: From Recruitment to Follow-up – Current Status of an MND-NET multicenter trial. (J. Dorst, Ulm)
- Efficacy And Tolerability Of β-Hydroxybutyrate In Patients With Amyotrophic Lateral Sclerosis (KETO-ALS) (C. Herrmann, Ulm)
- Clinical applicability of the OPM classification in ALS: a retrospective cohort study (A. Demleiter, TUM)